FIELD: medicine, phthisiology.
SUBSTANCE: method involves administration of roncoleukin by lymphotropic route: subcutaneously, in region of pretracheal cellular tissue in the equal dose 1/4-1/5 of the average daily therapeutic dose, once in one or two days, 3 injections for a course. Invention provides the local delivery of roncoleukin to the injure zone directly that promotes to making depot of the latter in the injure focus and to the rapid elimination of pathogen from body of patients. Invention can be used for correction of immune insufficiency in patients with pulmonary tuberculosis.
EFFECT: improved method for correction.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD TO TREAT PULMONARY TUBERCULOSIS | 1994 |
|
RU2104046C1 |
METHOD FOR INDIRECT REGIONAL LYMPHOTROPIC CHEMOTHERAPY IN INFILTRATIVE, DESTRUCTIVE AND DRUG-RESISTANT PULMONARY TUBERCULOSIS | 2004 |
|
RU2281093C2 |
METHOD OF TREATING PULMONARY TUBERCULOSIS IN HIV-INFECTION PATIENTS | 2008 |
|
RU2383342C1 |
METHOD FOR TREATING PULMONARY TUBERCULOSIS | 2004 |
|
RU2253460C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF INFILTRATIVE TUBERCULOSIS AND INSPECIFIC PNEUMONIA | 2003 |
|
RU2257150C2 |
METHOD OF TREATING PATIENTS WITH DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2015 |
|
RU2587332C1 |
METHOD FOR TREATING ALLERGIC DISEASES OF RESPIRATORY TRACT | 2001 |
|
RU2209092C2 |
METHOD FOR TREATING INFILTRATIVE PULMONARY TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE | 2016 |
|
RU2650633C2 |
METHOD FOR TREATMENT OF DESTRUCTIVE AND PROGRESSING LUNG TUBERCULOSIS FORMS CAUSED BY DRUG-RESISTANT STRAINS OF MYCOBACTERIUM TUBERCULOSIS | 2000 |
|
RU2215538C2 |
METHOD OF IMMUNOCORRECTION OF MAIN COURSE OF TREATMENT OF DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2012 |
|
RU2480206C1 |
Authors
Dates
2005-06-27—Published
2004-01-28—Filed